Our findings of higher TMEM doorway score and macrophage density in Black patients with ER + /HER2- breast cancer compared to White patients contribute to this growing understanding of how the TME-driven racial disparities impact clinical outcomes. The gene discussed is ESR1; the disease is breast carcinoma.